WT1-AS: A Potential Drug Target and Biomarker for Various Diseases

Target Name: WT1-AS

NCBI ID: G51352

WT1-AS

WT1-AS: A Potential Drug Target and Biomarker for Various Diseases

WT1-AS (WT1-Actinin-1) is a protein that is expressed in various tissues of the body, including the brain, pancreas, and muscle. It is a key regulator of the actinin complex, a protein that is involved in many cellular processes in the cell.

Recent studies have identified WT1-AS as a potential drug target for the treatment of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. This is because WT1-AS has been shown to play a role in the development and progression of these diseases , and may be a useful target for therapeutic intervention.

One of the reasons for the potential of WT1-AS as a drug target is its involvement in the regulation of actinin dynamics. Actinins are a type of protein that is involved in the regulation of cell division, and are essential for the proper execution of many cellular processes. WT1-AS is a key regulator of actinin dynamics, and has been shown to play a role in the regulation of cell division, cell migration, and the formation of tissues.

In addition to its role in actinin dynamics, WT1-AS has also been shown to be involved in the regulation of many other cellular processes. For example, it has been shown to play a role in the regulation of protein synthesis, cell signaling, and the development of cancer.

WT1-AS has also been shown to be involved in the development and progression of various diseases, including cancer. For example, studies have shown that high levels of WT1-AS are associated with the development of pancreatic cancer, and that inhibition of WT1- AS has been shown to be effective in the treatment of pancreatic cancer.

In addition to its potential as a drug target, WT1-AS has also been shown to be a useful biomarker for the diagnosis and prognosis of various diseases. For example, studies have shown that elevated levels of WT1-AS are associated with poor prognosis in patients with colorectal cancer, and that inhibition of WT1-AS has been shown to be effective in the treatment of colorectal cancer.

Overall, WT1-AS is a protein that has been shown to play a role in the regulation of actinin dynamics and many other cellular processes. Its potential as a drug target and biomarker make it an attractive target for therapeutic intervention in a wide range of diseases . Further research is needed to fully understand the role of WT1-AS in these diseases and to develop effective treatments.

Protein Name: WT1 Antisense RNA

The "WT1-AS Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about WT1-AS comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets